¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"idiopathic myocardial hypertrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® hypertrophy ÇÑ±Û ºñ´ë
¼³¸í   
  Àå±â Á¶Á÷À» ±¸¼ºÇϰí Àִ ¼¼Æ÷°¡ ¿ø·¡ÀÇ ±¸Á¶´Â À¯ÁöÇϸ鼭 ¼öÀû º¯µ¿¾øÀÌ ±× ¿ëÀû¸¸ Ä¿Áø »óÅÂ. °á°úÀûÀ¸·Î ±× Á¶Á÷ Àå±âÀÇ ¿ëÀû°ú Áß·®ÀÌ ºÒ¾î³ª°Ô µÇ´Â °ÍÀ» ¸»ÇÑ´Ù. À̶§ ¼¼Æ÷°¡ Ä¿Áø °ÍÀº ¼¼Æ÷Á¾Ã¢ ¶Ç´Â ºÎÁ¾°ú °°ÀÌ ¼öºÐ Èí¼ö°¡ Áõ°¡ÇÑ °ÍÀÌ ¾Æ´Ï°í ¼¼Æ÷ ³» ±¸Á¶¹°ÀÇ ÇÕ¼ºÀÌ Áõ°¡µÇ±â ¶§¹®ÀÌ´Ù. ºñ´ë´Â »ý¸®Àû È¤Àº º´ÀûÀÏ ¼ö ÀÖ°í ±â´ÉÀû ºÎÇϰ¡ Áõ´ëµÇ°Å³ª ¶Ç´Â Æ¯º°ÇÑ ³»ºÐºñ Àڱؿ¡ ÀÇÇØ ÀϾ´Ù. ºñ´ë´Â ´ÙÀ½°ú °°ÀÌ ºÐ·ùÇÒ ¼ö ÀÖ´Ù. ¨ç ÀÛ¾÷ºñ´ë: ¿îµ¿¼±¼öÀÇ ±ÙÀ°, °íÇ÷¾ÐÀ̳ª ÆÇ¸·ÁõÀÇ ½ÉÀå±Ù, ÀÓ½ÅÀÚ±ÃÀÇ ºñ´ë µî, ¨è ´ë»ó¼º ºñ´ë: ÇÑÂÊ ÄáÆÏÀ» ÀûÃâÇÏ¿´À» ¶§ ´Ù¸¥ ÂÊ ÄáÆÏ¿¡¼­ ÀϾ´Â ºñ´ë µî, ¨é È£¸£¸ó¼º ºñ´ë: ³úÇϼöüȣ¸£¸óÀÇ ÀÛ¿ëÀ¸·Î °Å´ÜÁõ-°ÅÀÎÁõÀÌ »ý±â´Â °æ¿ì µî, ¨ê ¿°Áõ¼º ºñ´ë: ¸¸¼º¿°¿¡ À־ÀÇ À§³ª ÄÚ¾ÈÁ¡¸·ÀÇ ºñ´ë µî, ¨ë Æ¯¹ß¼º ºñ´ë: ´Ù¸ðÁõ-ºñ´ÃÁõ-³»Àåºñ´ëÁõ µî°ú °°Àº ¿øÀκҸíÀÇ ¼±Ãµ¼º ¹ßÀ°À̻󿡠ÀÇÇÑ ºñ´ë µîÀÌ ÀÖ´Ù.
  
  
¿µ¹® myocardial infarction ÇÑ±Û ½É±Ù°æ»öÁõ
¼³¸í   
  ½ÉÀå¿¡ ÇǸ¦ °ø±ÞÇϴ Ç÷°üÀÌ ¸·Çô¼­, ±× µ¿¸Æ¿¡ ÀÇÇØ ¿µ¾çºÐÀ» °ø±Þ¹Þ´Â ºÎÀ§°¡ ±«»ç(Á״´ٴ ¶æ)¿¡ ºüÁö´Â °ÍÀ» ¸»ÇÔ. ÁַΠµ¿¸Æ°æÈ­Áõ(µ¿¸Æ¿¡ Áö¹æ¼ººÐ, ÁַΠÄÝ·¹½ºÅ×·Ñ µîÀÌ ½×¿© µ¿¸ÆÀÌ ±»¾î¼­ µüµüÇØÁö´Â º´Àû»óÅÂ) µîÀ¸·Î Ç÷°üÀÌ Á¼¾ÆÁ® Àִ »óÅ¿¡¼­ Ç÷Àü(ÀûÇ÷±¸, Ç÷¼ÒÆÇ µî ÇÇÀÇ ¼ººÐÀÌ ¹¶Ãļ­ ¹ß»ý) ÀÌ ¹ß»ýÇϰųª, Áö³ªÄ£ µ¿¸Æ°æÈ­ÁõÀÚü µî¿¡ ÀÇÇØ ¹ß»ýÇÑ´Ù. ÇöÀ砹̱¹ µî, ¼±Áø±¹¿¡¼­ÀÇ °¡Àå Å« »ç¸Á¿äÀÎÀÌ µÇ°í ÀÖ´Ù.¡¡ ¶ÇÇÑ ÀÌ ÁÖÀ§¿¡´Â ´ë°³ ½É±ÙÇãÇ÷ºÎÀ§°¡ Á¸ÀçÇϴµ¥ ÀÌ ºÎÀ§´Â ÇöÀç Çǰ¡ ¸ðÀÚ¶ó¼­ ¸· ±«»ç¿¡ ºüÁö±â Á÷ÀüÀÇ ¼¼Æ÷°¡ Àִ ºÎÀ§ÀÌ´Ù. µû¶ó¼­ ÀÌ ÇãÇ÷»óÅ¿¡¼­ ºü¸¥ Ä¡·á¸¦ ½ÃÇàÇÏ¿© Çǰ¡ °ø±ÞµÇ¸é, ÀÌ ºÎÀ§´Â Á¤»óÀûÀΠ»óÅ·ΠµÇ°ÚÁö¸¸, ¸¸¾à °è¼Ó ÀÌ »óÅ·ΠÀÖ°Ô µÇ¸é, ¾ðÁ¨°¡´Â ¿ª½Ã °æ»öÁõ¿¡ ºüÁ® ½ÉÀå¿îµ¿¿¡ ¸·´ëÇÑ ÁöÀåÀ» ÃÊ·¡ÇϰԠµÉ °ÍÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñ´ë, ºñ´ëĪ»çÀ̸·ºñ´ë
  • anabolic hypertrophy
    µ¿È­ºñ´ë
  • benign masseteric hypertrophy
    ¾ç¼º±ú¹°±Ùºñ´ë, ¾ç¼º±³±Ùºñ´ë
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³»ùºñ´ë, ¾ç¼ºÀü¸³¼±ºñ´ë
  • compensatory hypertrophy
    º¸»óºñ´ë
  • concentric hypertrophy
    µ¿½Éºñ´ë
  • denture hypertrophy
    ÀÇÄ¡Á¶Á÷ºñ´ë
  • false hypertrophy
    °ÅÁþºñ´ë
  • gum hypertrophy
    ÀÕ¸öºñ´ë
  • hypertrophy
    ºñ´ë
  • physiologic hypertrophy
    »ý¸®Àûºñ´ë
  • papillomatous hypertrophy
    À¯µÎÁ¾¸ð¾çºñ´ë
  • pseudomuscular hypertrophy
    °ÅÁþ±ÙÀ°ºñ´ë, °¡¼º±ÙÀ°ºñ´ë
  • ventricular hypertrophy
    ½É½Çºñ´ë
  • vicarious hypertrophy
    ´ë»óºñ´ë
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • idiopathic pulmonary fibrosis
    Ư¹ß¼ºÆó¼¶À¯Áõ
  • idiopathic crescentic glomerulonephritis
    Ư¹ßÃʽ´ÞÅ丮ÄáÆÏ¿°, Ư¹ßÃʽ´޻籸ü½Å¿°
  • hypertrophy
    ºñ´ë
  • gum hypertrophy
    ÀÕ¸öºñ´ë
  • ventricular hypertrophy
    ½É½Çºñ´ë
  • acute idiopathic polyneuritis
    ±Þ¼ºÆ¯¹ß¿©·¯½Å°æ¿°, ±Þ¼ºÆ¯¹ß´Ù¹ß½Å°æ¿°
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic myocardial hypertrophy
    Ư¹ß½É±Ùºñ´ë, ¿øÀκҸí½É±Ùºñ´ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • myocardial anoxia
    ½ÉÀå±ÙÀ°¹«»ê¼ÒÁõ
  • myocardial bridging
    ½É±Ù´Ù¸®
  • myocardial contractility
    ½ÉÀå±ÙÀ°¼öÃà·Â, ½ÉÀå±ÙÀ°¼öÃ༺
  • myocardial contraction
    ½ÉÀå±ÙÀ°¼öÃà
  • myocardial failure
    ½É±Ù±â´É»ó½Ç, ½É±ÙºÎÀü
  • myocardial depressant factor
    ½ÉÀå±Ù¾ïÁ¦ÀÎÀÚ
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial irritability
    ½É±Ù°ú¹Î¼º, ½É±ÙÀÚ±ØÈïºÐ¼º
  • myocardial ischemia
    ½É±ÙÇãÇ÷
  • septal myocardial infarction
    Á߰ݽɱٰæ»öÁõ
  • silent myocardial infarction
    ¹«Áõ»ó½É±Ù°æ»öÁõ
  • transmural myocardial infarction
    ÀüÃþ½É±Ù°æ»öÁõ
  • myocardial lead
    ½É±ÙÀ¯µµ
  • myocardial
    ½ÉÀå±ÙÀ°-, ½É±Ù-
  • myocardial scan
    ½ÉÀå±ÙÀ°½ºÄµ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Infarction, myocardial
    °æ»öÁõ(ÌÛßáñø)
  • anterior (myocardial) infarction
    Àüº®(½É±Ù)°æ»öÁõ.
  • high lateral myocardial infarction
    È޾߼øÈ¯°íÀ§Ãøº®½É±Ù°æ»öÁõ(ÍÔêÈö°ÛúãýÐÉÌÛßáñø ).
  • primary myocardial disease
    ¿ø¹ß(¼º) ½É±ÙÁúȯ(ê«Û¡àõãýÐÉòðü´).
  • primary myocardial disease
    ¿ø¹ß(¼º) ½É±ÙÁúȯ(ê«Û¡(àõ) ãýÐÉòðü´)
  • q wave,in myocardial infarction
    ½É±Ù°æ»öÀÇ (QÆÄ)(ãýÐÉÌÛßá¡­)
  • gingival hypertrophy
    Ä¡Àººñ´ë(Áõ)(öÍó»ÝþÓÞñø).
  • hemagiectatic hypertrophy
    Ç÷°üÈ®À强 ºñ´ëÁõ(úìηüªíåàõÝþÓÞñø).
  • hypertrophy
    ºñ´ë(Áõ)
  • hypertrophy
    ºñ´ë
  • hypertrophy (megalocardia)
    ºñ´ë (°Å´ë½ÉÀåÁõ)
  • hypertrophy of dental root
    Ä¡Àººñ´ë.
  • hypertrophy of right ventricle
    ¿À¸¥½É½Çºñ´ëÁõ
  • hypertrophy of the palatine tonsil
    ±¸°³Æíµµºñ´ëÁõ
  • hypertrophy, cardiac
    ½ÉÀåºñÈÄ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic myocardial hypertrophy
    Ư¹ß¼º ½É±Ùºñ´ëÁõ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñÈÄ.
  • asymmetric septal hypertrophy
    ºñ´ëμº Á߰ݺñ´ë(ÞªÓßöààõ ñḛ́ÝþÓÞ)
  • asymmetric septal hypertrophy
    ºñ´ëĪÁ߰ݺñÈÄ
  • asymmetric ventricular hypertrophy
    ºñ´ëμº ½É½Çºñ´ëÁõ.
  • asymmetry (unilateral hypertrophy)
    ºñ´ëĪ(ÇÑÂʺñ´ë)
  • atrial hypertrophy
    ½É¹æºñ´ë(ãýÛ®ÝþÓÞ).
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³¼±ºñ´ë(Áõ)(¡­îñí¡àÊÝþÓÞñø).
  • big heel =endemic hypertrophy of os calcis
    ºñÈÄ Á¾ºÎ(Ýþý§ñ¢Ý»), Á¾ºÎ Áö¹æ¼º ºñÈÄ(ñ¢Ý»ò¢Û°àõÝþý§), Å« µÚ²ÞÄ¡, À¯Ç༺ Á¾°ñÁ¾·ù(¡­ñ¢Íéðþ×»).
  • biventricular hypertrophy
    ¾ç(Ãø)½É½Çºñ´ë(å»[ö°]ãýãøÝþÓÞ).
  • biventricular hypertrophy
    ¾ç½É½Ç ºñ´ë
  • biventricular hypertrophy
    ¾ç(Ãø)½É½Çºñ´ë(å»ö°ãýãøÝþÓÞ).
  • cardiac hypertrophy
    ½É(Àå)ºñ´ë(ãýíôÞ¡ÓÞ).
  • cell,hypertrophy
    ºñÈÄ(Ýþý§)
  • clitoral hypertrophy
    À½ÇÙºñ´ë
  • combined ventricular hypertrophy
    º¹ÇÕ¼º ½É½Çºñ´ë.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Asymmetry (Unilateral hypertrophy)
    ºñ´ëĪ(ÇÑÂʺñ´ë)
    [¿¾ ¿ë¾î] ºñ´ëĪ
  • Myocardial primordium
    ½ÉÀå±ÙÀ°Ãþ¿ø±â
    [¿¾ ¿ë¾î] ½É±ÙÃþ¿ø±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • idiopathic pentosuria
    Ư¹ß¼º(÷åÛ¡àõ) ÆæÅ佺´¢Áõ(Òãñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • benign prostatic hypertrophy
    ¾ç¼ºÀü¸³¼±ºñ´ë(Áõ)
  • compensatory hypertrophy
    º¸»ó¼ººñ´ë
  • hypertrophy
    ºñ´ë, ºñÈÄ
  • muscular hypertrophy
    ±Ù(À°)ºñ´ë
  • prostatic hypertrophy
    Àü¸³¼±ºñ´ë
  • idiopathic
    Ư¹ß¼ºÀÇ
  • idiopathic hypertrophic osteoarthropathy
    Ư¹ß¼º°úÇü¼º°ñ°üÀýº´Áõ
  • idiopathic respiratory distress syndrome
    Ư¹ß¼ºÈ£Èí°ï¶õÁõÈıº
  • idiopathic retroperitoneal fibrosis
    Ư¹ß¼ºÈĺ¹¸·°­¼¶À¯Áõ
  • idiopathic thrombocytopenic purpura
    Ư¹ß¼ºÇ÷¼ÒÆÇ °¨¼Ò¼º Àڹݺ´
  • idiopathic unilateral hyperlucent lung
    Ư¹ß¼ºÀÏÃø¼º°úÅõ°ú¼ºÆó
  • myocardial
    ½É±ÙÀÇ
  • myocardial fibrosis
    ½É±Ù¼¶À¯Áõ
  • myocardial infarction
    ½É±Ù°æ»öÁõ
  • myocardial ischemia
    ½É±ÙÇãÇ÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
IMH idiopathic myocardial hypertrophy; indirect microhemagglutination [test]
IPH idiopathic portal hypertension; idiopathic pulmonary hemosiderosis; idiopathic pulmonary hypertensio...
AMI acquired monosaccharide intolerance; acute myocardial infarction; amitriptyline; anterior myocardial...
IMI immunologically measurable insulin; impending myocardial infarction; Imperial Mycological Institute ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ASH Asymmetric septal hypertrophy
ASH Asymmetrical septal hypertrophy
B.P.H. Benign Prostatic Hypertrophy
COH Compensatory ovarian hypertrophy
CHRPE Congenital hypertrophy of the retinal pigment epithelium
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • myocardial anoxia
    ½É±Ù ¹«»ê¼ÒÁõ
  • myocardial contractility
    ½É±Ù ¼öÃà·Â
  • myocardial contusion
    ½É±Ù Á»ó
  • myocardial degeneration
    ½É±Ù º¯¼º
  • myocardial depressant factor
    ½É±Ù ¾ïÁ¦ ÀÎÀÚ
  • myocardial failure
    ½É±Ù ºÎÀü
  • myocardial function
    ½É±Ù ±â´É
  • myocardial infarction
    ½É±Ù °æ»öÁõ, ½É±Ù °æ»ö
    1. °ü»óµ¿¸ÆÀ¸·ÎºÎÅÍÀÇ Ç÷·ù°¡ µÎÀýµÇ°í ½É±ÙÀÇ ÀϺΰ¡ »ê¼Ò °áÇÌÀ¸·Î ÀÎÇØ ±«»ç¿¡ ºüÁø °ÍÀ» ¸»ÇÑ´Ù. ±«»çÀÇ ¹üÀ§¿¡ µû¶ó¼­ ¿¹ÈÄ´Â ´Ù¸¥µ¥ ÀϹÝÀûÀ¸·Î Ä¡¸í·üÀÌ ³ôÀº ÁßÁõÀÇ ÁúȯÀÌ´Ù. °ü»ó µ¿¸ÆÀÇ Á×»ó °æÈ­¿¡ µû¸¥ Æó»öÀÌ ÁÖ¿ä º´ÀÎÀ̱⠶§¹®¿¡ Áß³â ÀÌÈÄÀÇ Æ¯È÷ ³²ÀÚ¿¡°Ô¼­ ¸¹ÀÌ º¼ ¼ö ÀÖ´Ù. °ü»ó µ¿¸ÆÀÇ ¿¬ÃàÀ̳ª Æó»öÀÌ ¿øÀÎÀÌ µÇ´Â ¼öµµ ÀÖ´Ù. ÀÓ»ó Áõ»óÀº Áö¼ÓÀûÀÌ°í ½ÉÇÑ Çù½ÉÁõ°ú °°Àº ÅëÁõ ¹ßÀÛÀ» ³ªÅ¸³»°í Ç÷¾ÐÀÌ Çϰ­ÇÏ°í ¶§·Î´Â ¼îÅ© »óŰ¡ µÇ´Â ¼öµµ Àִµ¥ °ÅÀÇ Áõ»óÀÌ ¾øÀÌ °æ°úÇÏ´Â ¼öµµ ÀÖ´Ù. 2. ½É±Ù ºÎÀ§ÀÇ ÇãÇ÷¼º ±«»çÀÌ´Ù. ½É±Ù °æ»öÁõÀº ÇãÇ÷¼º ½ÉÀå ÁúȯÀÇ Ãʱâ Áõ»óÀÏ ¼ö ÀÖÁö¸¸, ȯÀÚµéÀº ±Þ¼º ½É±Ù °æ»öÁõ Àü¿¡ Çù½ÉÁõÀ» °æÇèÇÏ°Ô µÈ´Ù. ½É±Ù °æ»öÁõÀÇ ÀÓ»óÀû ÇüÅ´ °æµµÀÇ °æ¿ìºÎÅÍ ÀϽÃÀû Çù½ÉÁõÀÇ Áõ»ó±îÁö ´Ù¾çÇѵ¥ ÀÌ·¯ÇÑ ÀϽÃÀûÀÎ Áõ»ó¿¡´Â ½É±Ù ±«»ç¸¦ ÀÏÀ¸Å°´Â °Í°ú °°Àº ½ÇÁ¦ÀûÀÎ Áø´ÜÀº ³»·ÁÁöÁö ¾Ê´Â´Ù. ´ÙÀ½°ú °°Àº 3°¡Áö ÈÄÀ¯ÁõÀÌ ¸ðµç ½É±Ù °æ»öÁõ ȯÀڵ鿡°Ô¼­ ³ªÅ¸³­´Ù. 1
  • myocardial irritability
    ½É±Ù °ú¹Î¼º, ½É±Ù ÀÚ±Ø ÈïºÐ¼º
  • myocardial lead
    ½É±Ù À¯µµ
  • myocardial necrosis
    ½É±Ù ±«»ç
  • myocardial primordium
    ½ÉÀå ±ÙÀ°Ãþ ¿ø±â
  • myocardial scan
    ½É±Ù ÁÖ»ç
  • myocardial stimulants
    ½É±Ù ÀÚ±ØÁ¦
  • acute idiopathic thrombocytopenic purpura
    ±Þ¼º Ư¹ß¼º Ç÷¼ÒÆÇ °¨¼Ò¼º ÀÚ¹Ý º´
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
adaptive hypertrophy Thickening of the walls of a hollow organ, like the urinary bladder, when there is obstruction to outflow.
(05 Mar 2000)
benign prostatic hypertrophy <urology> A benign enlargement of the prostate gland begins normally after age 50 years probably secondary to the effects of male hormones. If significant enlargement occurs, it may pinch off te urethra making urination difficult or impossible.
See: urinary retention.
(06 Aug 1998)
giant hypertrophy of gastric mucosa Gastric mucosal hyperplasia, either mucoid or glandular; the latter type may be associated with the Zollinger-Ellison syndrome.
Synonym: giant hypertrophy of gastric mucosa, hypertrophic gastritis, Menetrier's syndrome.
(05 Mar 2000)
gingival hypertrophy <dentistry> The abnormal enlargement of the gingiva surrounding the teeth caused by poor oral hygiene.
(08 Jan 1998)
vicarious hypertrophy Hypertrophy of an organ following failure of another organ because of a functional relationship between them; e.g., enlargement of the pituitary gland, after destruction of the thyroid.
(05 Mar 2000)
right ventricular hypertrophy <radiology> Pulmonary valve stenosis, pulmonary hypertension, tetralogy of Fallot, VSD
(12 Dec 1998)
physiologic hypertrophy Temporary increase in size of an organ or part to provide for a natural increase of function, such as the kind that occurs in the walls of the uterus and in the mammae during pregnancy.
Synonym: functional hypertrophy.
(05 Mar 2000)
compensatory hypertrophy Increase in size of an organ or part of an organ or tissue, when called upon to do additional work or perform the work of destroyed tissue or of a paired organ.
(05 Mar 2000)
compensatory hypertrophy of the heart Thickening of the walls of the heart in response to vascular, valvular, other heart disease, or athletic conditioning.
(05 Mar 2000)
complementary hypertrophy Increase in size or expansion of part of an organ or tissue to fill the space left by the destruction of another portion of the same organ or tissue.
(05 Mar 2000)
concentric hypertrophy Thickening of the walls of the heart or any cavity with apparent diminution of the capacity of the cavity.
(05 Mar 2000)
haemangiectatic hypertrophy <syndrome> A congenital malformation syndrome characterised by the triad of asymmetric limb hypertrophy, haemangiomata, and nevi. Asymmetric limb hypertrophy is enlargement of one limb and not the corresponding limb on the other side, the enlarged limb being 3 times more likely to be a leg than an arm in ktw; and the limb enlargement is of bone as well as soft tissue. The haemangiomas, abnormal nests of blood vessels that proliferate inappropriately and excessively, cover a remarkable range from small innocuous capillary haemangiomas ( strawberry marks ) to huge cavernous haemangiomas. The nevi are pigmented moles on the skin; in ktw there are often also dark linear streaks on the skin, streaks due to too much pigment. There can be other abnormalities but the triad is the consistent clinical centrepiece of the disease. most persons with ktw have an enlarged leg and do relatively well without treatment or, for example, with only compression from an elastic stocking. Skin ulcers and other skin problems can occur over the swollen leg. Usually, the treatment is conservative. Surgery is almost never needed. The only possible exceptions are the very rare situations in which the leg reaches gigantic proportions or secondary clotting difficulties arise (due to trapping and destruction of blood platelets in a huge haemangioma). Then, amputation may become necessary. The cause of ktw syndrome is unknown.
(12 Dec 1998)
simple hypertrophy Increase in size of cells.
(05 Mar 2000)
simulated hypertrophy Increased size of a part due to continued growth unrestrained by attritions, as is seen in the case of the teeth of certain animals when the opposing teeth have been destroyed.
(05 Mar 2000)
hypertrophy The enlargement or overgrowth of an organ or part due to an increase in size of its constituent cells.
Compare: hyperplasia.
Origin: Gr. Troph = nutrition
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hypertrophy
    ºñ´ë;ºñ´ëÇϰÔÇÏ´Ù;ºñ´ëÇØÁö´Ù
  • idiopathic
    Ư¹ß¼ºÀÇ;¾î¶² °³Àο¡ ƯÀ¯ÇÑ °íÀ¯ÀÇ
  • myocardial
    ½É±ÕÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á